SCHEMBL14641571

SCHEMBL14641571

CCCCOc1cc(OCCCC)c(C(C)=O)cc1C=O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 2/20 0.51
▸ TSHR P16473 2/20 0.51
▸ CA9 Q16790 3/20 0.44
▸ LMNA P02545 4/20 0.41
▸ L3MBTL1 Q9Y468 2/20 0.41
▸ MAPT P10636 2/20 0.41
▸ KMT2A Q03164 2/20 0.39
▸ TDP1 Q9NUW8 2/20 0.38
▸ GAA P10253 1/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ KDM4E B2RXH2 3/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ PSEN1 P49768 1/20 0.37
▸ PSEN2 P49810 1/20 0.37
▸ APH1B Q8WW43 1/20 0.37
▸ NCSTN Q92542 1/20 0.37
▸ APH1A Q96BI3 1/20 0.37
▸ PSENEN Q9NZ42 1/20 0.37
▸ ALDH1A1 P00352 2/20 0.37
▸ PTGDR2 Q9Y5Y4 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13241065 0.86 TDP1 (0.38) CYP3A4TSHRLMNAL3MBTL1MAPT
SCHEMBL10288012 0.85 CYP3A4 (0.43) CYP3A4TSHRCA9LMNAL3MBTL1
SCHEMBL9417892 0.83 CYP3A4 (0.41) CYP3A4TSHRLMNAL3MBTL1MAPT
SCHEMBL11317160 0.83 LMNA (0.47) TSHRLMNAL3MBTL1MAPTTDP1
SCHEMBL16482745 0.82 CYP3A4 (0.56) CYP3A4TSHRCA9LMNAL3MBTL1
SCHEMBL21017307 0.81 TSHR (0.69) CYP3A4TSHRCA9LMNAL3MBTL1
SCHEMBL14221843 0.79 TSHR (0.56) CYP3A4TSHRCA9LMNAL3MBTL1
SCHEMBL13206099 0.79 ERN1 (0.42) LMNAL3MBTL1TDP1GAASMN1; SMN2
SCHEMBL8293084 0.79 ALDH1A1 (0.63) CYP3A4TSHRLMNAL3MBTL1MAPT
SCHEMBL28421317 0.78 LMNA (0.46) CYP3A4TSHRLMNAL3MBTL1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2332909-B1 HYDROXYBENZAMIDE DERIVATIVES AND THEIR USE AS INHIBITORS OF HSP90 ASTEX THERAPEUTICS LTD (GB) 2014-10-15 — — EP disclosed
EP-1877379-B1 HYDROXYBENZAMIDE DERIVATIVES AND THEIR USE AS INHIBITORS OF HSP90 ASTEX THERAPEUTICS LTD (GB) 2013-01-16 — — EP disclosed
Send feedback